A rating of 84 puts Spero Therapeutics Inc (SPRO) near the top of the Biotechnology industry according to InvestorsObserver. Spero Therapeutics Inc's score of 84 means it scores higher than 84% of stocks in the industry. Spero Therapeutics Inc also received an overall rating of 68, putting it above 68% of all stocks. Biotechnology is ranked 32 out of the 148 industries.

Finding the best stocks can be tricky. It isnt easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObservers tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObservers overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. Theres no need to try to remember what is good for a bunch of complicated ratios, just pay attention to which numbers are the highest.

Spero Therapeutics Inc (SPRO) stock is lower by -7.34% while the S&P 500 has risen 0.16% as of 10:58 AM on Tuesday, Dec 29. SPRO has fallen -$1.62 from the previous closing price of $22.07 on volume of 181,432 shares. Over the past year the S&P 500 has gained 16.15% while SPRO has risen 109.31%. SPRO lost -$4.21 per share the over the last 12 months.

Click Here to get the full Stock Score Report on Spero Therapeutics Inc (SPRO) Stock.

Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.

You May Also Like

Go here to see the original:
Should You Buy Spero Therapeutics Inc (SPRO) in Biotechnology Industry? - InvestorsObserver